Clinical outcomes of hyperprogression based on volumetry in non-small cell lung cancer after immune checkpoint inhibitor treatment.
Je Hun KimTaeyun KimTae Won JangHee KangMi Hyun KimSeong Hoon YoonChoon-Hee SonHyun-Kyung LeeHyun-Kuk KimShin-Yup LeeKyeong Choel ShinJi-Yeon HanEun-Ju KangPublished in: Thoracic cancer (2022)
There is no standardized definition of HPD. However, defining HPD in NSCLC patients treated with ICI using a semiautomatic volume measurement software is feasible.